Michael Scolaro

Michael Scolaro

Oct 30, 2017

Group 6 Copy 211
4
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Synthesis of a Kidney Cancer Drug

We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

How good are North American mosquitoes at spreading Zika virus?

Zika virus (ZIKV) is usually transmitted by Aedes mosquitoes. In different geographic locations...

Backer Badge Funded